Loncastuximab
ADC Therapeutics
['adctherap']
the #eha2023 hybrid congress kicks off today in frankfurt! we're excited to share data on our cd19-targeted #antibodydrugconjugate with the #hematology community tomorrow. view details of our presentation here: 
Leading the development & commercialization of next-generation antibody drug conjugates with highly potent and targeted pyrrolobenzodiazepine dimer technology